Revvity Shares Slide 4% Despite Q4 Earnings and Revenue Beat

Group 1 - Revvity, Inc. reported fourth-quarter results that exceeded analyst expectations for both earnings and revenue, with adjusted earnings per share at $1.70 compared to the consensus estimate of $1.55 and revenue totaling $772.06 million, surpassing expectations of $758.53 million [1] - Quarterly revenue increased by 6% from $729 million a year earlier, with organic growth of 4%. GAAP earnings per share rose to $0.87 from $0.78 in the prior-year period [2] - The Diagnostics segment led performance with a 10% increase in revenue to $390 million, including 7% organic growth, while Life Sciences revenue increased by 2% to $382 million, though organic revenue for this segment was flat year over year [2] Group 2 - For the full year 2025, Revvity reported adjusted earnings per share of $5.06, up from $4.90 in 2024, while total revenue rose to $2.86 billion from $2.76 billion [3] - Looking ahead, the company initiated fiscal 2026 guidance, projecting revenue of $2.96 billion to $2.99 billion, above the $2.94 billion consensus estimate, and adjusted earnings per share were forecast at $5.35 to $5.45, exceeding analyst expectations of $5.32 [3]